PTH / Parathyroid hormone · Western blot design guide

Design a Western Blot for PTH

Real validated PTH Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PTH WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for PTH: expected band ~12.9 kDa, hero antibody M00208-2, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable PTH Western blot protocol sheet — expected band ~12.9 kDa, antibody M00208-2, controls and PMC citations. Open the full PTH WB guide →

PTH Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~12.9 kDa
Gel 15% (standard starting point)
Positive control ⓘ Parathyroid gland (IHC candidate; verify WB)
Negative control ⓘ Adipose tissue (IHC candidate; verify WB)
Important caveats
Reasons your observed band may differ from the expected size.
PTM Cleaved
Caveat Precursor processing
Gene-set association MSigDB C7 membership
Isoform 1 isoform(s)
Section 1

Real Curated PTH Western Blot Protocols

The M00208-2 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysatehuman Parathyroid Hormone recombinant protein (catalog M00208-2)
Gel %15% (standard starting point)
Load20–30 µg total protein per lane; optimize for abundance (standard starting point)
TransferShort semi-dry transfer; verify retention (standard starting point)
Membrane0.2 µm PVDF (standard starting point)
Blocking5% milk or 5% BSA in TBST (standard starting point)
Primary antibodyM00208-2; use the WB datasheet starting dilution (standard starting point)
Primary incubationOvernight at 4 °C (standard starting point)
Secondary antibodySpecies-matched HRP conjugate at validated dilution (standard starting point)
Secondary incubation1 h at room temperature (standard starting point)
Wash3 × 5 min in TBST (standard starting point)
DetectionECL; bracket exposures to avoid saturation (standard starting point)
Section 2

What Is the Expected PTH Western Blot Band Size?

The PTH precursor is predicted at 12.9 kDa; annotated cleavage may yield smaller PTH, but no empirical migration is supplied.

What am I looking at on my blot?
Band near 12.9 kDaMay represent the full-length PTH precursor; confirm its identity.
Band below 12.9 kDaMay represent PTH after signal-peptide and propeptide cleavage.
Bands near and below 12.9 kDaCould reflect precursor and processed PTH; confirm both identities.
Little or no band in whole-cell lysatePTH is secreted.
💡Expected PTH appearanceUniProt predicts 12.9 kDa for the PTH precursor; signal-peptide and propeptide cleavage may yield a smaller band, but no empirical band size is supplied, so confirm band identity with appropriate controls.
How each factor affects band size
UniProt-predicted precursor massPlaces the full-length 115-residue PTH precursor near 12.9 kDa.
Signal peptide at residues 1–25Its cleavage makes PTH smaller than the full-length precursor.
Propeptide at residues 26–31Its cleavage further reduces the size of processed PTH.
Combined precursor processingRemoval of both annotated segments yields a smaller mature product; its apparent mass is not supplied.
Why is my band missing or off?
SituationLikely causeNext action
No band in lysatePTH is secreted.Check conditioned medium or another relevant secreted fraction.
Band higher than expectedThe band may contain uncleaved PTH precursor.Compare precursor and secreted fractions and verify band identity.
Band lower than expectedSignal-peptide and propeptide cleavage may reduce PTH size.Check whether the antibody recognizes processed PTH and verify the band.
Multiple bandsPrecursor and processed PTH may coexist.Compare cellular and secreted fractions and confirm each band’s identity.
Weak or no signalSecreted PTH may be scarce in the tested fraction.Check sample fraction, loading, and a suitable positive control.

Sample controls for PTH Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for PTH in Western blot, you can use parathyroid gland tissue.
Positive control: Parathyroid gland (IHC candidate; verify WB)
Negative control: Adipose tissue (IHC candidate; verify WB)
Loading controls: Run GAPDH, β-actin, and a total-protein stain such as Ponceau alongside the samples.
⚠️Feasibility: PTH is secreted, so tissue lysates may give weak signal; consider testing the secreted fraction.

HPA tissue expression evidence for PTH

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Parathyroid gland glandular cells High Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Adipose tissue adipocytes Not detected Protein (IHC) HPA →
Adrenal gland glandular cells Not detected Protein (IHC) HPA →
Appendix glandular cells Not detected Protein (IHC) HPA →
Bone marrow hematopoietic cells Not detected Protein (IHC) HPA →
Breast adipocytes Not detected Protein (IHC) HPA →
Section 3

Advanced PTH Western Blot Tips

Deeper troubleshooting and optimisation questions for PTH, answered from its protein features.

How should PTH band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Do annotated PTH isoforms explain multiple bands?
Isoforms · UniProt lists one isoform and no alternative sequence. Its annotated signal peptide and propeptide offer a processing-related possibility to investigate, but the supplied features do not identify the cause of any extra band.
Are annotated PTH modifications likely to explain a shifted band?
PTM · The supplied UniProt record lists no glycosylation sites, modified residues, or disulfides. It therefore provides no specific modification to test as the cause of a shift. Compare any observed bands with the precursor and processed regions before assigning an explanation.
Does this guide establish induction of PTH?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
What transfer method to use for PTH Western blot?
Transfer · PTH is annotated as a 115-residue precursor with a shorter processed hormone comprising residues 32..115. Select and validate a transfer setup that retains small proteins; check retention with a suitable small-protein control. The UniProt features do not specify a particular transfer method.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the M00208-2 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
Which sample fraction is relevant when quantifying PTH?
Quantitation · UniProt identifies PTH as secreted. For secreted PTH, collect the extracellular fraction and keep collection volume and cell input consistent across samples. State whether the assay targets processed PTH or the 115-residue precursor, since the annotated signal peptide and propeptide distinguish them.
Why might PTH migrate differently from its predicted 12.9 kDa mass?
Interpretation · The 12.9 kDa prediction describes the 115-residue precursor. UniProt annotates a signal peptide at residues 1..25 and a propeptide at 26..31, leaving residues 32..115 in the processed hormone. These features suggest different molecular sizes, but no observed band is supplied, and cleavage alone does not establish a particular apparent mass.

Choose an antibody whose epitope lies within residues 32..115 if the goal is to detect processed PTH. An epitope restricted to the annotated signal peptide (1..25) or propeptide (26..31) would target precursor regions removed during processing. Confirm the vendor's residue numbering against UniProt precursor coordinates.

Check whether the antibody recognizes residues retained in processed PTH (32..115) or the precursor regions (1..31), using UniProt precursor numbering. The record lists one isoform and no modification sites, while the apparent band position is unavailable. These features alone cannot assign an unexpected band to a specific PTH form.
Boster reagents

PTH Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of Parathyroid Hormone expression in human Parathyroid Hormone recombinant protein.
Anti-Parathyroid Hormone Rabbit Monoclonal Antibody
Cat # M00208-2

M00208-2 is a rabbit monoclonal anti-PTH antibody listed as human-reactive. Its Western blot image shows human recombinant PTH; the supplied evidence does not establish performance in endogenous samples.

Which to pick: M00208-2 is the only listed antibody. Choose it if human reactivity and a Western blot image using recombinant PTH fit your design; no comparison with other antibodies is supplied.

Source: BosterBio PTH gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.

References

  1. UniProt Consortium. UniProt entry P01270.
  2. Human Protein Atlas. PTH tissue expression.
  3. PMC11952747 — target-verified WB comparison